摘要
目的探讨miR-141-3p及其靶基因在结直肠癌患者血浆中的表达,及其与临床病理和治疗预后的关系。方法收集结直肠癌患(试验组)者手术前后的血浆和健康志愿者(对照组)血浆各150例,利用实时定量聚合酶链反应(RT-qPCR)检测血浆中miR-141-3p、磷酸酶与张力蛋白同源物(PTEN)、转化生长因子Ⅱ型受体(TGF-β2)和p53的表达水平,统计分析其与结直肠癌病理特征和手术疗效的相关性。结果手术前与对照组比较,试验组血浆中miR-141-3p和p53的表达显著上升(P<0.01),而PTEN和TGF-β2的表达则显著下降(P<0.01)。手术后,试验组血浆中miR-141-3p和p53的表达显著下调(P<0.05),而PTEN和TGF-β2的表达则显著上调(P<0.05)。miR-141-3p的表达水平与结直肠癌肿瘤分化和浸润程度、TNM分期及转移等有显著相关性(P<0.05)。miR-141-3p高表达患者的术后复发率较高、生存率也较差(P<0.05)。结论血浆miR-141-3p在结直肠癌临床诊断和治疗预后中有潜在应用价值。
Objective To investigate the expressions of miR-141-3p and its target genes in the plasma of patients with colorectal cancer,and the relationship with clinicopathological characteristics and prognosis.Methods Plasma of 150 colorectal cancer patients(the experimental group)before and after surgery and 150 healthy volunteers(the control group)were collected.The expression of miR-141-3p,phosphatase and tensin homolog deleted on chromosome 10(PTEN),transforming gromth faetor-β2(TGF-β2)and p53 in plasma were detected by real-time quantitative polymerase chain reaction(RT-qPCR).Its correlation with the clinicopathological characteristics and surgical efficacy of colorectal cancer was statistically analyzed.Results Compared with the control group,the expression of miR-141-3p and p53 in the experimental group significantly increased(P<0.01),while the expression of PTEN and TGF-β2 significantly decreased(P<0.01).After operation,the expression of miR-141-3p and p53 was significantly down-regulated(P<0.05),while the expression of PTEN and TGF-β2 was significantly up-regulated(P<0.05).The expression of miR-141-3p was significantly correlated with the tumor differentiation and invasion,TNM stages and metastasis(P<0.05).Patients with miR-141-3 p high expression showed a higher recurrence rate(P<0.05)and a worse survival rate(P<0.05).Conclusion Plasma miR-141-3 p showed potential value in clinical diagnosis and prognosis of colorectal cancer.
引文
[1]JIN Y Y,CHEN Q J,XU K,et al.Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemoresistance in esophageal cancer cells via regulation of PTEN[J].Mol Cell Biochem,2016,422(1):161-170.
[2]LIU C Z,YE Z H,MA J,et al.A qRT-PCR and gene functional enrichment study focused on downregulation of miR-141-3p in hepatocellular carcinoma and its clinicopathological significance[J].Technol Cancer Res Treat,2017,16(6):835-849.
[3]LI J Z,LI J,WANG H Q,et al.MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression[J].Biochem Biophys Res Commun,2017,482(4):1381-1386.
[4]ZHOU X,WU W N,ZENG A L,et al.MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53[J].Oncotarget,2017,8(41):71080-71094.
[5]FENG J J,XUE S,PANG Q Y,et al.miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1in keloids[J].Biochem Biophys Res Commun,2017,490(2):302-308.
[6]周欣亮,赵日旸,韩晶,等.miR-141-3p在胃癌组织和患者血浆中的表达及其临床意义[J].中国肿瘤生物治疗杂志,2017,24(10):1112-1117.
[7]王亚南,陈昭华,严岱红.血清microRNA-141在结肠癌中的表达和临床意义[J].临床检验杂志,2014,32(4):255-258.
[8]YE J,WANG Z,ZHAO J,et al.MicroRNA-141inhibits tumor growth and minimizes therapy resistance in colorectal cancer[J].Mol Med Rep,2017,15(3):1037-1042.
[9]FENG L,MA H Q,CHANG L,et al.Role of microRNA-141in colorectal cancer with lymph node metastasis[J].Exp Ther Med,2016,12(5):3405-3410.
[10]WU P P,ZHU H Y,SUN X F,et al.MicroRNA-141regulates the tumor suppressor DLC-1in colorectal cancer[J].Neoplasma,2015,62(5):705-712.
[11]JI J,QIN Y F,REN J,et al.Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN[J].Sci Rep,2015,5:16262.
[12]LEI K C,LIANG X,GAO Y W,et al.Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFbeta 2feedback loop[J].Biochem Biophys Res Commun,2017,484(3):514-521.
[13]周欣亮,王玉栋,张难,等.胃癌组织TGF-β对miR-200c/141表达影响的研究[J].中华肿瘤防治杂志,2017,24(8):552-556.
[14]朱玉兵,万燕青.腹腔镜与开腹手术治疗大肠癌临床对比探究[J].结直肠肛门外科,2016,22(S1):151-152.
[15]马玉宝,朱海林.腹腔镜与内镜微创术联合治疗大肠癌的疗效观察[J].结直肠肛门外科,2017,23(2):177-180.
[16]张丽静,孟丽敏,樊智彬,等.大肠癌患者血浆miR-106a的表达及意义[J].南方医科大学学报,2014,34(3):354-357.
[17]SCHMITTGEN T D,LIVAK K J.Analyzing real-time PCR data by the comparative C(T)method[J].Nat Protoc,2008,3(6):1101-1108.
[18]韦皓棠,陈利生.粪便miRNA检测在结直肠癌诊断中的价值[J].结直肠肛门外科,2017,10(5):565-569.
[19]熊兵红,马利,程勇,等.miR-21在大肠癌中的表达及其靶基因探讨[J].南京医科大学学报(自然科学版),2014,34(3):281-286.
[20]张鑫,陈悦,张天彪,等.大肠癌中Dicer与miRNA-155表达及临床意义[J].临床军医杂志,2016,44(10):1055-1058.
[21]卫星,宋卫东,牟永平,等.mTOR和PTEN基因在大肠癌组织中的表达及临床意义[J].职业与健康,2015,31(8):1041-1044.
[22]罗赵鑫,陈仰新,罗先桃,等.VEGF、EGFR、Ki-67及p53的表达与大肠癌浸润转移的相关性[J].中国热带医学,2015,15(11):1369-1371.
[23]HUANG S,WA Q,PAN J,et al.Downregulation of miR-141-3p promotes bone metastasis via activating NF-κBsignaling in prostate cancer[J].J Exp Clin Cancer Res,2017,36(1):173.
